NAD searches are up 601% alongside 'peptide therapy'. Here's why longevity clinics already changed their mind
“NAD+ isn't a peptide. It's co-searched with 'peptide therapy' at a 601% year-on-year growth rate. That tells you everything about how the category is expanding.”
The chart that tells the story
"NAD" searches on Google are up 601% year-on-year, co-trending with "peptide therapy" (+281%). It's the highest co-search multiplier in the longevity category — higher than GLP-1 (+177%), higher than anti-aging (+162%).
Except — NAD+ isn't a peptide. It's a nucleotide coenzyme. So why is it riding the peptide wave?
Because the buyer doesn't care about the definition
The person Googling "peptide therapy" is looking for a category, not a molecule. And NAD+ sits exactly where that buyer wants it: mitochondrial, cellular, injectable-optional, clinic-sold, longevity-coded.
Clinics figured this out first. By late 2025, Dubai's wellness clinics were listing "peptide + NAD+ protocols" as a single bundle. By early 2026, the major US longevity practices had followed.
What NAD+ actually does
NAD+ is the central coenzyme for cellular energy metabolism and sirtuin activation. Levels decline with age; restoring them theoretically supports mitochondrial function, DNA repair, and stress resistance.
The clinical evidence is more mixed than the marketing suggests — strong on mechanism, modest on outcome trials, still early on long-term safety. Most academic programmes favour NAD+ precursors (NMN, NR) delivered orally over direct IV NAD+.
Why clinics bundle it with peptides
- Same buyer. Someone on tesamorelin or sermorelin is already optimising metabolism.
- Same price point. NAD+ IV costs £200–£500; peptide cycles land in the same range. Easy to cross-sell.
- Experience mirrors. Both are "you feel something" compounds. Unlike generic supplements.
- Protocol overlap. MOTS-c stacks into NAD+ protocols naturally (mitochondrial overlap).
What to buy, and how
- Oral precursors (NMN, NR) — slowest path, lowest cost, clearest safety profile. Life Extension and integrative supplement brands cover this well.
- IV NAD+ — clinic-only, £200–£500 per drip.
- Subcutaneous NAD+ — the research-peptide compromise. We track three vendors with NAD+ vials.
Pair it with
- MOTS-c for mitochondrial overlap.
- Epitalon if you're already on a pineal protocol.
- Retatrutide if weight loss is the primary goal — NAD+ doesn't replace GLP-1 but complements it metabolically.